INDP Indaptus Therapeutics, Inc.

Fundamentals / CIK 0001857044 / USD

Indaptus Therapeutics, Inc. reported $31.21M in total assets and a net loss of $13.50M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open INDP in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

6 fiscal years (2020 to 2025), reported in USD.

$0$0$0-$19.49MFY 2020 Net Income: -$3.58M2020FY 2021 Net Income: -$7.71M2021FY 2022 Net Income: -$14.32M2022FY 2023 Net Income: -$15.42M2023FY 2024 Net Income: -$15.02M2024FY 2025 Net Income: -$20.85M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $9.34M $7.25M $7.62M $6.32M $2.52M $2.66M
Total Operating Expenses $19.83M $15.37M $16.38M $14.91M $7.73M $3.60M
Operating Income -$19.83M -$15.37M -$16.38M -$14.91M -$7.73M -$3.60M
EBITDA -- -$15.37M -$16.38M -$14.91M -$7.73M -$3.60M
Income Before Tax -$20.85M -$15.02M -- -- -- --
Income Tax Expense $1.7K $1.7K $2.5K $30 $1.6K $800
Net Income -$20.85M -$15.02M -$15.42M -$14.32M -$7.71M -$3.58M
Basic EPS -$21.58 -$44.96 -$51.26 -$48.46 -$52.94 -$51.54
Diluted EPS -$21.58 -$44.96 -$51.26 -$48.46 -$52.94 -$51.54
Basic Shares Outstanding 966.1K 334.1K 299.9K 295.0K 146.0K 69.4K
Diluted Shares Outstanding 966.1K 334.1K 299.9K 295.0K 146.0K 69.4K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $271K $363K $491K $2.85M $1.52M $2.17M $2.81M $2.48M
Total Operating Expenses $1.14M $1.81M $2.16M $8.16M $2.65M $4.46M $4.57M $4.17M
Operating Income -$1.14M -$1.81M -$2.16M -$8.16M -$2.65M -$4.46M -$4.57M -$4.17M
EBITDA -- -- -- -- -- -- -- -$4.17M
Net Income -$1.05M -$1.79M -$2.54M -$8.11M -$2.98M -$5.23M -$4.53M -$4.13M
Basic EPS -$0.01 -$0.02 -$0.23 -- -$2.98 -$9.09 -$9.11 --
Diluted EPS -$0.01 -$0.02 -$0.23 -- -$2.98 -$9.09 -$9.11 --
Basic Shares Outstanding 133.2M 116.1M 11.0M -- 997.0K 574.9K 497.8K --
Diluted Shares Outstanding 133.2M 116.1M 11.0M -- 997.0K 574.9K 497.8K --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $8.51M $5.79M $13.36M $9.63M $39.13M $1.64M
Short-Term Investments -- -- -- $16.81M -- --
Cash & Short-Term Investments $8.51M $5.79M $13.36M $26.43M $39.13M $1.64M
Total Current Assets $9.31M $6.62M $14.00M $27.24M $40.39M $1.73M
Property, Plant & Equipment, Net -- -- $735 $2.0K $3.8K $1.3K
Other Non-Current Assets -- $638K $755K $738K $16K $44K
Total Non-Current Assets $0 $720K $929K $820K $189K $46K
Total Assets $9.31M $7.34M $14.92M $28.06M $40.58M $1.78M
Accounts Payable $544K $870K $806K $1.38M $2.54M $156K
Total Current Liabilities $6.16M $3.39M $2.77M $3.43M $4.60M $2.02M
Other Non-Current Liabilities -- -- -- -- -- $691K
Total Non-Current Liabilities $0 $0 $73K $0 $73K $1.03M
Total Liabilities $6.16M $3.39M $2.85M $3.43M $4.68M $2.02M
Total Debt (incl. Leases) -- $84K $175K $80K $169K $934K
Common Stock $22K $4.3K $84K $84K $83K $19K
Retained Earnings -$81.29M -$60.44M -$45.42M -$29.99M -$15.67M -$7.96M
Accumulated Other Comp. Income -- -- -- $96K -- --
Total Stockholders' Equity $3.15M $3.94M $12.08M $24.63M $35.90M -$238K
Total Equity $3.15M $3.94M $12.08M $24.63M $35.90M -$238K

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Cash & Cash Equivalents $26.60M $7.55M $8.51M $5.83M $6.16M $3.89M $5.79M $7.38M
Short-Term Investments $4.00M $4.00M -- -- -- -- -- --
Cash & Short-Term Investments $30.60M $11.55M $8.51M $5.83M $6.16M $3.89M $5.79M $7.38M
Other Current Assets $27K $28K -- -- -- -- -- --
Total Current Assets -- -- $9.31M $6.44M $6.41M $4.96M $6.62M $7.63M
Other Non-Current Assets -- -- -- $393K $393K $393K $638K $505K
Total Non-Current Assets -- -- $0 $401K $426K $451K $720K $610K
Total Assets $31.21M $11.99M $9.31M $6.84M $6.84M $5.41M $7.34M $8.24M
Accounts Payable $172K $509K $544K $707K $619K $1.31M $870K $556K
Total Current Liabilities -- -- $6.16M $2.23M $8.51M $2.61M $3.39M $2.23M
Total Non-Current Liabilities -- -- $0 $0 $0 $0 $0 $4.0K
Total Liabilities $20.88M $615K $6.16M $2.23M $8.51M $2.61M $3.39M $2.24M
Total Debt (incl. Leases) -- -- -- $8.7K $34K $60K $84K $108K
Common Stock $1.33M $1.33M $22K $16K $6.0K $160K $4.3K $102K
Retained Earnings -$86.67M -$85.62M -$81.29M -$73.18M -$70.20M -$64.97M -$60.44M -$56.31M
Total Stockholders' Equity $10.33M $11.37M $3.15M $4.61M -$1.67M $2.80M $3.94M $6.00M
Total Equity $10.33M $11.37M $3.15M $4.61M -$1.67M $2.80M $3.94M $6.00M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$20.85M -$15.02M -$15.42M -$14.32M -$7.71M -$3.58M
Depreciation & Amortization -- $735 $1.3K $1.8K $1.4K $852
Stock-Based Compensation $1.36M $2.31M $2.97M $2.96M $1.51M $140K
Operating Cash Flow -$14.82M -$12.32M -$13.41M -$13.08M -$11.29M -$3.32M
Capital Expenditure -- -- -- -- -$3.9K --
Free Cash Flow -- -- -- -- -$11.29M --
Purchases of Investments -- -- -$6.86M -$29.60M -- --
Investing Cash Flow -- -- $17.14M -$16.43M $448K --
Common Stock Issued $6.40M $5.51M -- -- -- --
Financing Cash Flow $17.54M $4.75M -- -- $48.34M $1.16M
Net Change in Cash $2.72M -$7.58M $3.74M -$29.51M $37.49M -$2.16M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$1.05M -$1.79M -$2.54M -$8.11M -$2.98M -$5.23M -$4.53M -$4.13M
Depreciation & Amortization -- -- -- -- -- -- -- $0
Stock-Based Compensation $8.4K -$64K $227K $786K $151K $181K $241K $304K
Operating Cash Flow -$1.44M -$1.93M -$7.01M -$3.19M -$2.57M -$4.02M -$5.05M -$3.40M
Common Stock Issued -- -- -- -$154 $2.34M $575K $3.48M $2.14M
Financing Cash Flow -- -- -- $5.87M $2.24M $6.28M $3.15M $1.80M
Net Change in Cash $19.05M $6.06M -$7.01M $2.68M -$332K $2.27M -$1.90M -$1.59M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -661.5% -380.8% -127.7% -58.2% -21.5% --
Return on Assets (ROA) -223.9% -204.7% -103.3% -51.0% -19.0% -201.6%
Current Ratio 1.51x 1.95x 5.05x 7.94x 8.77x 0.86x
Quick Ratio 1.38x 1.71x 4.82x 7.70x 8.50x 0.81x
Debt to Equity -- 0.02x 0.01x 0.00x 0.00x --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -130.6% -135.6% -- -661.5% -366.2% -- -562.5% -380.8%
Return on Assets (ROA) -43.2% -128.7% -- -223.9% -246.6% -248.0% -291.0% -204.7%
Current Ratio -- -- -- 1.51x 2.88x 0.75x 1.90x 1.95x
Quick Ratio -- -- -- 1.38x 2.61x 0.72x 1.49x 1.71x
Debt to Equity -- -- -- -- 0.00x -- 0.02x 0.02x
Source: SEC EDGAR CompanyFacts (CIK 0001857044) · from March 31, 2020 Data through September 30, 2026 · synced Nov 20, 2026, 05:39 UTC · Open in terminal